Use of a RAR-&ggr;-specific agonist ligand for increasing the rate of apoptosis

US6506796B1 · kind B1 · utility

Assignee

• Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · FR

Inventors

• Laszlo Fesus · Debrecen, HU
• Zsuzsa Szondy · Debrecen, HU
• Uwe Reichert · Schlüchtern, DE

Key dates

• Filing date: Jul 25, 2000
• Grant date: Jan 14, 2003
• Expiry date: Sep 12, 2020

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Methods of cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of 6-3-(1-adamantyl)-4-hydroxyphenyl)-2-naphthanoic acid.